Kazutaka Obama

Prof. Kazutaka Obama

Kyoto University Hospital, Kyōto, Japan
orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
TYTakehito Yamamoto
Takehito Yamamoto
KKKenji Kawada
Kenji Kawada
KOKazutaka Obama
Kazutaka Obama
Colorectal cancer (CRC) is the leading cause of cancer deaths around the world. It is necessary to identify patients with poor prognosis or with high risk for recurrence so that we can selectively perform intensive treatments such as preoperative and/or postoperative chemotherapy and extended surgery. The clinical usefulness of inflammation-related prognostic biomarkers available from routine blood examination has been reported in many types of cancer, e.g., neutrophil–lymphocyte ratio (NLR), lymphocyte–C-reactive protein ratio (LCR), platelet–lymphocyte ratio (PLR), lymphocyte–monocyte ratio (LMR), and so on. Moreover, some scoring systems based on circulating blood cell counts and albumin concentration have been also reported to predict cancer patients’ prognosis, such as the Glasgow prognostic score (GPS), systemic inflammation score (SIS), and prognostic nutritional index (PNI). The optimal biomarker and optimal cutoff value of the markers can be different depending on the cancer type. In this review, we summarize the prognostic impact of each inflammation-related marker in CRC.

1 January 2011 in Surgery
Verified
Journal Article
Closed access
KOKazutaka Obama
Kazutaka Obama
HOHiroshi Okabe
Hiroshi Okabe
HHHisahiro Hosogi
Hisahiro Hosogi
ETEiji Tanaka
Eiji Tanaka
AIAtsushi Itami
Atsushi Itami
YSYoshiharu Sakai
Yoshiharu Sakai

Verified
Journal Article
Open access
PDF file
MOMichio Okamoto
Michio Okamoto
RMRei Mizuno
Rei Mizuno
KKKenji Kawada
Kenji Kawada
YIYoshiro Itatani
Yoshiro Itatani
YKYoshiyuki Kiyasu
Yoshiyuki Kiyasu
KOKazutaka Obama
Kazutaka Obama
Neutrophil extracellular traps (NETs) play important roles in host immunity, as there is increasing evidence of their contribution to the progression of several types of cancers even though their role in colorectal cancers (CRCs) remains unclear. To investigate the clinical relevance of NETs in CRCs, we examined the expression of citrullinated histone H3 using immunohistochemistry and preoperative serum myeloperoxidase–DNA complexes in CRC patients using an enzyme-linked immunosorbent assay. High expression of intratumoral or systemic NETs was found to correlate with poor relapse-free survival (RFS), for which it is an independent prognostic factor. In vitro investigations of CRC cells (HCT116, HT29) revealed that NETs did not affect their proliferation but did promote the migration of CRC cells mediated by neutrophil elastase (NE) released during NETosis to increase extracellular signal-regulated kinase (ERK) activity. In vivo experiments using nude mice (KSN/slc) revealed that NE inhibition suppressed liver metastases in CRC cells, although it did not affect the growth of subcutaneously implanted tumors. Taken together, these results suggest that NET formation correlates with poor prognoses of patients with CRC and that the inhibition of NE could be a potential therapy for CRC metastases.

28 May 2015 in Surgery Today
Verified
Journal Article
Closed access
PDF file
KOKazutaka Obama
Kazutaka Obama
YSYoshiharu Sakai
Yoshiharu Sakai

9 December 2019 in Surgical Endoscopy
Verified
Journal Article
Closed access
PDF file
KMKatsuhiro Murakami
Katsuhiro Murakami
KOKazutaka Obama
Kazutaka Obama
STShigeru Tsunoda
Shigeru Tsunoda
SHShigeo Hisamori
Shigeo Hisamori
TNTatsuto Nishigori
Tatsuto Nishigori
YSYoshiharu Sakai
Yoshiharu Sakai

1 April 2020 in Translational Gastroenterology and Hepatology
Verified
Journal Article
Open access
PDF file
TNTatsuto Nishigori
Tatsuto Nishigori
KOKazutaka Obama
Kazutaka Obama
YSYoshiharu Sakai
Yoshiharu Sakai
Malnutrition is a critical problem in patients with gastric cancer (GC); however, no universally accepted marker that is convenient for clinical use has been defined. Recently, body composition has attracted considerable attention as a means to assess nutrition status in patients with cancer. The clinical role of skeletal muscle mass has also been increasingly recognized. In patients with GC, sarcopenia, which is the loss of skeletal muscle mass, was found to be significantly associated with increased post-surgical complications including hospital stay, healthcare costs, and poor survival. In addition, sarcopenic obesity, which combines the health risks of obesity and sarcopenia, is recognized as a strong risk factor for poor short- and long-term outcomes following gastrectomy. The mechanism linking sarcopenia to worse postoperative outcomes remains unclear; however, skeletal muscle has been found to act as an endocrine organ that produces substances affecting the immune system. In addition, sarcopenia was reported to be associated with toxicity and termination of chemotherapy. Patients with sarcopenia may be unable to react appropriately to the stress of gastrectomy and perioperative chemotherapy. To improve the short- and long-term outcomes of patients with GC and sarcopenia, adequate energy and protein intake are necessary during resistance training. In the present study, we performed a literature review and presented a method to evaluate body composition, the relationship between skeletal muscle mass and GC, and perioperative nutrition and exercise therapy for patients with sarcopenia.